IQVIA HoldingsMEX:IQV +3.84%76 FCF Margin % is 11.83% as of Mar. 2026, which is 11% above its 10-year median of 10.61. GuruFocus rates MEX:IQV with a GF Score™ of 76/100 and a GF Value™ of MXN4,360.58 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, IQVIA Holdings ranks better than 78.43% on this metric.
The historical rank and industry rank for IQVIA Holdings's FCF Margin % or its related term are showing as below:
MEX:IQV'
s FCF Margin % Range Over the Past 10 Years
Min: 6.19 Med: 10.61 Max: 16.59
Current: 12.69
During the past 13 years, the highest FCF Margin % of IQVIA Holdings was 16.59%. The lowest was 6.19%. And the median was 10.61%.
MEX:IQV's FCF Margin % is ranked better than 78.43% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs MEX:IQV: 12.69
IQVIA Holdings FCF Margin % Related Terms
IQVIA Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for IQVIA Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:IQV vs NTRA, ILMN, MTD: FCF Margin % Comparison
For the Diagnostics & Research subindustry, IQVIA Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IQVIA Holdings FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where IQVIA Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IQVIA Holdings (MEX:IQV) has a FCF Margin % of 11.83% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IQVIA Holdings and its competitors. This is 11% above median its historical median of 10.61. Over the past decade, IQVIA Holdings' FCF Margin % has ranged from 6.19 to 16.59. According to the industry distribution chart, IQVIA Holdings ranks #44 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 21.6%.
Is IQVIA Holdings' FCF Margin % too high?
IQVIA Holdings' current FCF Margin % of 11.83% is 11% above median its 10-year median of 10.61. Over the past 10 years, this metric has ranged from a low of 6.19 to a high of 16.59. Based on the distribution chart, IQVIA Holdings ranks #44 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, IQVIA Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' FCF Margin % compare to NTRA and ILMN?
According to the Medical Diagnostics & Research industry distribution chart, IQVIA Holdings ranks #44 out of 204 companies for FCF Margin %. This places IQVIA Holdings in the top 22% of its industry — outperforming the majority of peers. Historically, IQVIA Holdings' own FCF Margin % has ranged from 6.19 to 16.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current FCF Margin % is 11.83%, which is 11% above median its own 10-year median of 10.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (MEX:IQV) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN4,360.58, compared to a current price of MXN3,000.00 — trading 31.2% below its estimated fair value. The current FCF Margin % is 11.83%, which is 11% above median its 10-year median of 10.61. IQVIA Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For IQVIA Holdings (MEX:IQV), the current FCF Margin % is 11.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IQVIA Holdings (MEX:IQV) Overvalued in 2026?
Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued.
The current stock price of MXN3,000.00 is trading 31.2% below its estimated GF Value™ of MXN4,360.58.
GuruFocus considers IQVIA Holdings to be Significantly Undervalued.
Key valuation signals for MEX:IQV:
FCF Margin %: 11.83% (11% above median its 10-year median of 10.61)
GF Value™: MXN4,360.58 vs. price of MXN3,000.00 (31.2% below fair value)
No single metric tells the full story. See the MEX:IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
76GF Score
Get the complete analysis for MEX:IQV
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:IQV has been successfully added to your 
